Serial Number | 75828120 |
Word Mark | SULFAZINE DR |
Filing Date | Friday, October 22, 1999 |
Status | 606 - ABANDONED - NO STATEMENT OF USE FILED |
Status Date | Thursday, April 18, 2002 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 1000 - Typeset: Word(s) / letter(s) / number(s) |
Published for Opposition Date | Tuesday, January 23, 2001 |
Disclaimer with Predetermined Text | "DR" |
Goods and Services | pharmaceutical preparation, namely, an enteric coated tablet containing 500 mg of sulfasalazine used as an anti-inflamatory and an immunomodulatory agent |
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Wednesday, January 19, 2000 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | Qualitest Pharmaceuticals, Inc. |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 03 - Corporation |
Address | Huntsville, AL 35811 |
Party Name | Qualitest Pharmaceuticals, Inc. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | Huntsville, AL 35811 |
Event Date | Event Description |
Wednesday, June 4, 2003 | ABANDONMENT - NO USE STATEMENT FILED |
Tuesday, October 23, 2001 | EXTENSION 1 GRANTED |
Tuesday, October 9, 2001 | EXTENSION 1 FILED |
Tuesday, April 17, 2001 | NOA MAILED - SOU REQUIRED FROM APPLICANT |
Tuesday, January 23, 2001 | PUBLISHED FOR OPPOSITION |
Friday, December 22, 2000 | NOTICE OF PUBLICATION |
Friday, August 25, 2000 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Thursday, August 17, 2000 | EXAMINER'S AMENDMENT MAILED |
Monday, March 13, 2000 | NON-FINAL ACTION MAILED |
Tuesday, February 22, 2000 | ASSIGNED TO EXAMINER |